GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...

It’s not easy being one of Silicon Valley’s favorite benchmarks.

In this conversation, Helen Warrell, FT investigations reporter and former defense and security editor, and James O’Donnell, ...

Before the conference kicked off this year, host country Brazil’s president, Luiz Inácio Lula da Silva, cast this as the ...

In 2017, fresh off a PhD on theoretical chemistry, John Jumper heard rumors that Google DeepMind had moved on from building ...

MIT Technology Review’s senior reporter for features and investigations, Eileen Guo, and FT tech correspondent Melissa ...

Vitamin D appears to influence our immune health, too. Studies have found a link between low vitamin D levels and incidence ...

As enterprises seek to do more with less, VMware migrations offer a practical path to making progress on modernization goals ...

It can be challenging to quantify how much of a danger space debris poses. The International Civil Aviation Organization ...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

One of the dominant storylines I’ve been following through 2025 is electricity—where and how demand is going up, how much it ...

Manufacturing is getting a major system upgrade. As AI amplifies existing technologies—like digital twins, the cloud, edge ...